CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Highly Sensitized Patients Awaiting Kidney Transplant

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Tongji Hospital, Tongji Medical Collage of Huazhong University of Science & Technology, Wuhan, Hubei, China
Contact: Study coordinator (Gang Chen, Ph.D) · gchen@tjh.tjmu.edu.cn · 027-83662892

Study leads

Gang Chen
Principal Investigator
Tongji Hospital, Tongji Medical Collage of Huazhong University of Science & Technology

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

CAR-T Cell Therapy for Desensitization in Kidney Transplantation

Kidney Transplant · Kidney Failure · End Stage Renal Failure on Dialysis

Abroad (travel likely)RecruitingPHASE1

Boston, United States · New York, United States

Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET)

Kidney Failure, Chronic · Kidney Transplantation · Alloimmunization

Abroad (travel likely)RecruitingPHASE1, PHASE2

Barcelona, Spain